MedTrace Logo

Short-term Outcomes of Transanal Total Mesorectal Excision With Structured Training Curriculums in China

NCT05108753 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2021-11-05

No results posted yet for this study

Summary

Transanal total mesorectal excision (TaTME) is an alternative for mid-low rectal cancer. In China, this procedure has been performed in high-volume centers with structured training curriculums. This study aimed to evaluate the short-term outcomes during the initial implementation of the TaTME procedure in high-volume centers who followed structured training curriculums in China.

Conditions

Interventions

OTHER

Procedure/Surgery

Transanal Total Mesorectal Excision

Sponsors & Collaborators

  • Shanghai Minimally Invasive Surgery Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2021-04-30
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108753 on ClinicalTrials.gov